Skip to content

Efficacy of Manjishthadi Ghanavati and Siddharthakadi Lepa in the management of Mukhadushika (Acne vulgaris) in Adolescents

Efficacy of Mridu Virechana and Manjishthadi Ghanavati along with Siddharthakadi Lepa in the management 0of Mukhadushika w.s.r. to Acne vulgaris in Adolescents-An open labelled single arm clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083943
Enrollment
30
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Sponsors

ITRA Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Mukhadushika (Acne vulgaris) with age between 12 to 16 years of either sex willing to participate in the trial

Exclusion criteria

Exclusion criteria: Age group below 12 years and above 16 years. Mukhadushika (Pidika) on any region other than face. Children suffering from infectious and chronic systemic disorder like TB, HIV, Thyroid disorders, PCOD etc. Children with chromosomal, genetic, metabolic or congenital disorder. Patients taking any hormonal therapy.

Design outcomes

Primary

MeasureTime frame
To improve the signs and symptoms of Mukhadushika (Acne vulgaris). GAGS Score (BT and AT) Timepoint: 43 days

Secondary

MeasureTime frame
To improve the acne scars on the skin. Timepoint: 43 days

Countries

India

Contacts

Public ContactDr VK Kori

Institute of Teaching and Research in Ayurveda

drvkkori@yahoo.co.in09409207285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026